Harris Eyre

From Wikitia
Jump to navigation Jump to search
Harris Eyre
Add a Photo
  • Neuroscientist
  • Entrepreneur
  • Author

Harris Eyre is an Australian neuroscientist, entrepreneur and author.[1][2][3] He is an ex Forbes 30 Under 30 Asia Listmaker[4] and UCLA Fulbright Scholar.[5]

In his work he incorporates insights from precision medicine,[6] clinical care,[7] entrepreneurship,[8] convergence science,[9] consumer participation,[10] workforce development[11] and diplomacy.[12]


Dr Eyre grew up in Mackay, Queensland, Australia[13] and completed his undergraduate medical degree (Bachelor of Medicine, Bachelor of Surgery (MBBS) with Honours) at James Cook University in North Queensland, Australia.[14] His medical education specialized in rural, remote, Indigenous and Tropical health.[15] He then completed his PhD in Neuroscience at the University of Adelaide.[16] During his PhD, he was awarded the W.G. Walker Fulbright Scholarship to study at UCLA.[17] The WG Walker Fulbright Scholarship is awarded to the top Australian Fulbright Scholar annually.[18]



Harris has held a number of industry positions during his career.

He is currently President and Chief Medical Officer of PRODEO, a group of brain health-focused executives.[19] He is also Co-Founder of The PRODEO Institute, a think-tank focused on radically approaches to advancing brain health.[20]

Eyre was the Co-Founder and Chief Medical Officer of CNSdose, a company focused on personalized medication guidance.[21][22] CNSdose is noted for incorporating blood-brain-barrier genetics into their tool and publishing a Randomized Controlled Trial.[23][24] In 2016, the US Department of Veterans Affairs Health Administration noted CNSdose technology as "the most promising in an early field."[25] CNSdose is a Texas Medical Center Venture Fund Portfolio Company.[26]. CNSdose completed the Melbourne Accelerator Program in 2016 [27].


Eyre published 80 + articles and chapters[28]. In his research career, he has co-authored numerous works including the ‘Responsible Innovation in Mental Health ’ model, ‘Mental Health Innovation Diplomacy’ model, the 'Brain Health Innovation Diplomacy' model, the 'Mars Mental Health' model,[29] the 'Phase-specific Neuroimmune Model of Depression', a meta-analysis of chemokines in depression,[30] a meta-analysis of pharmacogenetic-based decision support tools for depression,[31] a randomized controlled trial of yoga to prevent dementia[32] and the model of 'Convergence Psychiatry'.[9]

He maintains an advisory role with Stanford’s Brainstorm Lab for Mental Health Innovation.[33] and an honorary position with The University of Melbourne's Department of Psychiatry.[1]

Public and media appearances

His academic work has been noted in the New York Times[34] and the Australian Financial Review.[35]


Eyre has been awarded various awards throughout his career including:

  • 2020 Innovation Award for the Australian American Chamber of Commerce[36]
  • 2018 Forbes 30 Under 30 Asia Listing[4]
  • 2015 W.G. Walker Fulbright Scholar[5]
  • 2017 Victorian State Finalist for Young Australian of the Year[37]
  • 2017 Outstanding Early Career Alumni Award for the College of Medicine and Dentistry at James Cook University[14]
  • 2013 Junior Medical Officer of the Year, Australian Medical Association of Queensland [38]


Selected research articles

  • H Eyre, BT Baune (2012) Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 37 (9), 1397–1416[39]
  • P Siddarth, AC Burggren, HA Eyre, GW Small, DA Merrill (2018) Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults. PloS one 13 (4), e0195549[40]
  • H Eyre, A Singh, C Reynolds (2016) Tech giants enter mental health. World Psychiatry 15 (1), 21-22[8]
  • HA Eyre, W Ellsworth, E Fu, HK Manji, M Berk (2020) Responsible innovation in technology for mental health care. The Lancet Psychiatry 7 (9), 728-730 [41]
  • D Chang, E Storch, L Black, M Berk, N Pellis, H Lavretsky, J Sutton, K Ternes, M Shepanek, E Smith, R Abbott, H. Eyre (2020) Promoting Tech Transfer Between Space and Global Mental Health. Aerosp Med Hum Perform 91 (9), 737-745 [42]


  1. 1.0 1.1 "Dr Harris Eyre". findanexpert.unimelb.edu.au.
  2. https://harriseyre.com/
  3. "Q&A with Dr. Harris Eyre, Psychiatry Trainee, Pharmacogeneticist • Student Doctor Network". March 12, 2018.
  4. 4.0 4.1 "Harris Eyre". Forbes.
  5. 5.0 5.1 "Dr Harris Eyre: a multi-faceted career while at UCLA". September 21, 2015.
  6. Abbott, Ryan; Chang, Donald D.; Eyre, Harris A.; Bousman, Chad A.; Merrill, David; Lavretsky, Helen (February 16, 2018). "Pharmacogenetic Decision Support Tools: A New Paradigm for Late-Life Depression?". The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry. 26 (2): 125–133. doi:10.1016/j.jagp.2017.05.012. PMC 5812821. PMID 29429869.
  7. Eyre, Harris; Baune, Bernhard; Lavretsky, Helen (September 16, 2015). "Clinical advances in geriatric psychiatry: a focus on prevention of mood and cognitive disorders". The Psychiatric Clinics of North America. 38 (3): 495–514. doi:10.1016/j.psc.2015.05.002. PMC 4548274. PMID 26300035.
  8. 8.0 8.1 Eyre, Harris A.; Singh, Ajeet B.; Reynolds, Charles (February 16, 2016). "Tech giants enter mental health". World Psychiatry. 15 (1): 21–22. doi:10.1002/wps.20297. PMC 4780298. PMID 26833598.
  9. 9.0 9.1 Eyre, Harris A.; Lavretsky, Helen; Forbes, Malcolm; Raji, Cyrus; Small, Gary; McGorry, Patrick; Baune, Bernhard T.; Reynolds, Charles (February 16, 2017). "Convergence Science Arrives: How Does It Relate to Psychiatry?". Academic Psychiatry : The Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry. 41 (1): 91–99. doi:10.1007/s40596-016-0496-0. PMC 5540327. PMID 26964782.
  10. Eyre, Harris A.; Becker, Elisabeth R. B.; Blumenthal, Marissa S.; Singh, Ajeet B.; Raji, Cyrus; Vahabzadeh, Arshya; Wainer, Zoe; Bousman, Chad (January 1, 2020). Baune, Bernhard T. (ed.). Chapter 6 - Consumer participation in personalized psychiatry. Academic Press. pp. 63–68 – via ScienceDirect.
  11. Eyre, Harris A.; Mitchell, Rob D.; Milford, Will; Vaswani, Nitin; Moylan, Steven (June 26, 2014). "Portfolio careers for medical graduates: implications for postgraduate training and workforce planning". Australian Health Review. 38 (3): 246–251. doi:10.1071/AH13203. PMID 24718035 – via www.publish.csiro.au.
  12. Ternes, Kylie; Iyengar, Vijeth; Lavretsky, Helen; Dawson, Walter; Booi, Laura; Ibanez, Agustin; Vahia, Ipsit; Reynolds, Charles; DeKosky, Steven; Cummings, Jeffrey; Miller, Bruce; Perissinotto, Carla; Kaye, Jeffrey; Eyre, Harris (February 1, 2020). "Brain Health INnovation Diplomacy: a Model Binding Diverse Disciplines to Manage the Promise and Perils of Technological Innovation". International Psychogeriatrics. 32 (8): 955–979. doi:10.1017/s1041610219002266. PMC 7423685. PMID 32019621.
  13. "Medical school opens a world of opportunities and success". Daily Mercury.
  14. 14.0 14.1 "Dr Harris Eyre". www.jcu.edu.au. April 26, 2020.
  15. "Study a Bachelor's Degree of Medicine & Surgery in Queensland". www.jcu.edu.au.
  16. https://digital.library.adelaide.edu.au/dspace/bitstream/2440/113319/1/01front.pdf
  17. "Fulbright Scholar to focus on age-related decline". www.adelaide.edu.au.
  18. "Australian Fulbright Alumni Association (AFAA) - WG Walker Fund". fulbrightalumni.org.au.
  20. "Home". Prodeo Institute.
  21. "CNSdose | Genetic Testing | Home". cnsdose.com.
  22. Connection, The Victorian (June 18, 2018). "CNSDose showcases DNA-guided depression treatment". connection.vic.gov.au.
  23. Commission, Australian Trade and Investment. "Copy of Codelco Procurement Program". Austrade.
  24. "CNSDose to Demonstrate Leading Genetic Technology for Prescribing Antidepressants at the American Psychiatric Association Annual Meeting". Benzinga.
  25. Peterson, Kim; Dieperink, Eric; Ferguson, Lauren; Anderson, Johanna; Helfand, Mark (September 16, 2011). Evidence Brief: The Comparative Effectiveness, Harms, and Cost-effectiveness of Pharmacogenomics-guided Antidepressant Treatment versus Usual Care for Major Depressive Disorder. Department of Veterans Affairs (US). PMID 27606389 – via PubMed.
  26. https://www.tmc.edu/news/2017/11/texas-medical-center-announces-25-million-tmc-venture-fund/
  27. "Melbourne Accelerator Program". www.themap.co.
  28. "Harris Eyre - Google Scholar". scholar.google.com.au.
  29. Chang, Donald D.; Storch, Eric A.; Black, Lance; Berk, Michael; Pellis, Neal; Lavretsky, Helen; Sutton, Jeffrey; Ternes, Kylie; Shepanek, Marc; Smith, Erin; Abbott, Ryan; Eyre, Harris A. (September 1, 2020). "Promoting Tech Transfer Between Space and Global Mental Health". Aerospace Medicine and Human Performance. 91 (9): 737–745. doi:10.3357/AMHP.5589.2020.
  30. Eyre, Harris A.; Air, Tracy; Pradhan, Alyssa; Johnston, James; Lavretsky, Helen; Stuart, Michael J.; Baune, Bernhard T. (July 4, 2016). "A meta-analysis of chemokines in major depression". Progress in Neuro-psychopharmacology & Biological Psychiatry. 68: 1–8. doi:10.1016/j.pnpbp.2016.02.006. PMC 5536843. PMID 26903140.
  31. Bousman, Chad A.; Arandjelovic, Katarina; Mancuso, Serafino G.; Eyre, Harris A.; Dunlop, Boadie W. (January 16, 2019). "Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials". Pharmacogenomics. 20 (1): 37–47. doi:10.2217/pgs-2018-0142. PMID 30520364.
  32. Eyre, Harris A.; Siddarth, Prabha; Acevedo, Bianca; Van Dyk, Kathleen; Paholpak, Pattharee; Ercoli, Linda; St Cyr, Natalie; Yang, Hongyu; Khalsa, Dharma S.; Lavretsky, Helen (April 16, 2017). "A randomized controlled trial of Kundalini yoga in mild cognitive impairment". International Psychogeriatrics. 29 (4): 557–567. doi:10.1017/S1041610216002155. PMC 5540331. PMID 28088925.
  33. "People". Stanford Brainstorm.
  34. "Yoga May Be Good for the Brain".
  35. "Ex Trade Minister Andrew Robb to advise genetic testing startup CNSDose". Australian Financial Review. July 11, 2016.
  36. "Australian American Chamber of Commerce SF - Innovation Awards". www.sfaussies.com.
  37. Choahan, Neelima (October 22, 2017). "Samuel Johnson among nominees for Victorian Australian of the Year awards". The Age.
  38. "Doctor Q November 2013". Issuu.
  39. Eyre, Harris; Baune, Bernhard T. (September 1, 2012). "Neuroplastic changes in depression: A role for the immune system". Psychoneuroendocrinology. 37 (9): 1397–1416. doi:10.1016/j.psyneuen.2012.03.019. PMID 22525700. S2CID 29560032 – via ScienceDirect.
  40. Siddarth, Prabha; Burggren, Alison C.; Eyre, Harris A.; Small, Gary W.; Merrill, David A. (April 12, 2018). "Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults". PLOS ONE. 13 (4): e0195549. Bibcode:2018PLoSO..1395549S. doi:10.1371/journal.pone.0195549. PMC 5896959. PMID 29649304.
  41. Cite error: Invalid <ref> tag; no text was provided for refs named auto
  42. Chang, Donald D.; Storch, Eric A.; Black, Lance; Berk, Michael; Pellis, Neal; Lavretsky, Helen; Sutton, Jeffrey; Ternes, Kylie; Shepanek, Marc; Smith, Erin; Abbott, Ryan; Eyre, Harris A. (September 1, 2020). "Promoting Tech Transfer Between Space and Global Mental Health". Aerospace Medicine and Human Performance. 91 (9): 737–745. doi:10.3357/AMHP.5589.2020. PMID 32867906.

This article "Harris Eyre" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.